TCM
BLUE

TimesSquare Capital Management’s bluebird bio BLUE Stock Holding History

TimesSquare Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-14,660
Closed -$8.22M – 230
2020
Q4 		$8.22M Sell
14,660
-47,702
-76% -$30.2M 0.07% 206
2020
Q3 		$43.6M Sell
62,362
-10,020
-14% -$7.81M 0.41% 109
2020
Q2 		$57.2M Buy
72,382
+11,682
+19% +$8.81M 0.55% 72
2020
Q1 		$36.1M Buy
60,700
+18,165
+43% +$17.7M 0.43% 97
2019
Q4 		$48.3M Buy
+42,535
New +$46.2M 0.43% 103

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TimesSquare Capital Management's BLUE Position: Q1 2021 in Review

TimesSquare Capital Management sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 14,660 shares — an estimated $8.22M sold.

TimesSquare Capital Management first reported a position in BLUE in Q4 2019 and held it in 5 quarters. The position peaked at $57.2M in Q2 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • TimesSquare Capital Management reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • TimesSquare Capital Management sold 14,660 bluebird bio shares in Q1 2021, an estimated $8.22M.
  • TimesSquare Capital Management first reported a position in bluebird bio in Q4 2019 and held it in 5 quarters.
  • TimesSquare Capital Management's bluebird bio position peaked at $57.2M in Q2 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on TimesSquare Capital Management's 13F filing for Q1 2021, filed 12 May 2021.